Phase 3 Study of S-217622 in the Prevention of Symptomatic SARS_CoV-2 Infection
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Shionogi Inc.
Start Date
July 31, 2024
End Date
January 30, 2025
Administered By
Institutes and Centers
Awarded By
Shionogi Inc.
Start Date
July 31, 2024
End Date
January 30, 2025